Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4,0214,040 of 20,252 grants

Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT – ADMINISTRATIVE CORE The Administrative Core (AC) will provide organizational infrastructure for Virginia Commonwealth University - Massey Cancer Center...

Active RESEARCH CENTERS
PDX Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT U4HELPP PDX CORE A profound limitation to personalized approaches for therapeutic development in cancer is the lack of relevant patient derived models in...

Active RESEARCH CENTERS
Bioinformatics Core
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

Project Summary/Abstract The primary goal of the Bioinformatics Core of VCU’s U4HELPP is to provide data management, quality control, reproducible analyses, data storage, and data...

Active RESEARCH CENTERS
Research Project 1 PDAC Molecular Subtypes Contribute to Cancer Health Disparities
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease that is refractory to current treatment strategies due in part to adaptive mechanisms of chemoresistance...

Completed OTHER RESEARCH-RELATED
Targeting Menin Protein Stability In AML
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2025

PROJECT SUMMARY Multiple Endocrine Neoplasia Type 1 (MEN1/MENIN) is a transcriptional regulator known to interact with Lysine Methyltransferase 2A (KMT2A/MLL1) driving aggressive s...

$1.3M
USD
Completed TRAINING, INDIVIDUAL
Mechanism of Lupus La:miR-122 ribonucleoprotein sorting into breast cancer-derived exosomes
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT Extracellular vesicles (EVs) comprise a heterogeneous pool of membrane-enclosed compartments secreted to the extracellular milieu of cells. Eukaryotic ce...

$442K
USD
Completed OTHER RESEARCH-RELATED
Targeting Menin Protein Stability In AML
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2025

PROJECT SUMMARY Multiple Endocrine Neoplasia Type 1 (MEN1/MENIN) is a transcriptional regulator known to interact with Lysine Methyltransferase 2A (KMT2A/MLL1) driving aggressive s...

$1.3M
USD
Completed TRAINING, INDIVIDUAL
Mechanism of Lupus La:miR-122 ribonucleoprotein sorting into breast cancer-derived exosomes
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2023 – 2025

PROJECT SUMMARY / ABSTRACT Extracellular vesicles (EVs) comprise a heterogeneous pool of membrane-enclosed compartments secreted to the extracellular milieu of cells. Eukaryotic ce...

$457.3K
USD
Active OTHER RESEARCH-RELATED
Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow Transplant
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Summary Dr. Jonathan Webster is an Assistant Professor of Oncology in the Division of Hematologic Malignancies at The Johns Hopkins University School of Medicine. He is a m...

$2.37M
USD
Active NON-SBIR/STTR RPGS
DNA evaluation of fragments for early interception (DELFI) of Lung cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Summary Cell-free DNA in the blood provides a non-invasive diagnostic avenue for patients with cancer. Our groups have pioneered liquid biopsy approaches for detection and...

$7.45M
USD
Active OTHER RESEARCH-RELATED
TCI Mentored Medical Student Summer Scholars (TCI-MMSSS) Program
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

The goal of our Tisch Cancer Institute (TCI) Mentored Medical Student Summer Scholars (TCI-MMSSS) Program is to inspire medical students to pursue careers in cancer research throug...

$1.03M
USD
Completed TRAINING, INDIVIDUAL
Dual targeting of cGAS-STING and splicing to prime lung cancer immunogenicity
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

Project Summary Lung cancer is the leading cause of cancer-related death in the United States. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and despite...

$760.5K
USD
Completed TRAINING, INDIVIDUAL
Chemical Biology-Based Tools to Uncover the Function of PARP16 in cancer
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT PARP16, a member of the PARP family of enzymes responsible for carrying out the post-translational modification known as ADP-ribosylating, is emerging as a...

$476.9K
USD
Active OTHER RESEARCH-RELATED
Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow Transplant
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Summary Dr. Jonathan Webster is an Assistant Professor of Oncology in the Division of Hematologic Malignancies at The Johns Hopkins University School of Medicine. He is a m...

$2.37M
USD
Active OTHER RESEARCH-RELATED
TCI Mentored Medical Student Summer Scholars (TCI-MMSSS) Program
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

The goal of our Tisch Cancer Institute (TCI) Mentored Medical Student Summer Scholars (TCI-MMSSS) Program is to inspire medical students to pursue careers in cancer research throug...

$970.3K
USD
Active NON-SBIR/STTR RPGS
DNA evaluation of fragments for early interception (DELFI) of Lung cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Summary Cell-free DNA in the blood provides a non-invasive diagnostic avenue for patients with cancer. Our groups have pioneered liquid biopsy approaches for detection and...

$10.01M
USD
Completed TRAINING, INDIVIDUAL
Dual targeting of cGAS-STING and splicing to prime lung cancer immunogenicity
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

Project Summary Lung cancer is the leading cause of cancer-related death in the United States. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and despite...

$839.3K
USD
Completed TRAINING, INDIVIDUAL
Chemical Biology-Based Tools to Uncover the Function of PARP16 in cancer
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT PARP16, a member of the PARP family of enzymes responsible for carrying out the post-translational modification known as ADP-ribosylating, is emerging as a...

$489.7K
USD
Completed TRAINING, INDIVIDUAL
The impact of sepsis-induced inflammation on pancreatic cancer liver metastasis
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2025

1 PROJECT SUMMARY 2 Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic malignancy and the third-leading cause of 3 cancer-related death in adults. A majority of patient...

$476.9K
USD
Completed TRAINING, INDIVIDUAL
The impact of sepsis-induced inflammation on pancreatic cancer liver metastasis
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2025

1 PROJECT SUMMARY 2 Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic malignancy and the third-leading cause of 3 cancer-related death in adults. A majority of patient...

$489.7K
USD